{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:05:06Z","timestamp":1789718706879,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.amjmed.2009.01.033","type":"journal-article","created":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T10:35:13Z","timestamp":1245666913000},"page":"754-761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Raloxifene and Risk for Stroke Based on the Framingham Stroke Risk Score"],"prefix":"10.1016","volume":"122","author":[{"given":"Elizabeth","family":"Barrett-Connor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Mitlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2009.01.033_bib1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2009.01.033_bib2","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2009.01.033_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2009.01.033_bib4","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/jnci\/djn153","article-title":"Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk","volume":"100","author":"Grady","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.amjmed.2009.01.033_bib5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.287.7.847","article-title":"Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial","volume":"287","author":"Barrett-Connor","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2009.01.033_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/STROKEAHA.108.518621","article-title":"Effect of raloxifene on stroke and venous thromboembolism: a randomized controlled trial in postmenopausal women with or at increased risk of coronary heart disease","volume":"40","author":"Mosca","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.amjmed.2009.01.033_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/WNL.50.1.208","article-title":"Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989","volume":"50","author":"Petty","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2009.01.033_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.44.4.626","article-title":"Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study","volume":"44","author":"Sacco","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.amjmed.2009.01.033_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.STR.22.2.155","article-title":"Stroke recurrence within 2 years after ischemic infarction","volume":"22","author":"Hier","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.amjmed.2009.01.033_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.STR.22.3.312","article-title":"Probability of stroke: a risk profile from the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.amjmed.2009.01.033_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.STR.25.1.40","article-title":"Stroke risk profile: adjustment for antihypertensive medication","volume":"25","author":"D'Agostino","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.amjmed.2009.01.033_bib12","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1161\/01.STR.0000223048.70103.F1","volume":"37","author":"Goldstein","year":"2006","journal-title":"Stroke"},{"issue":"7375","key":"10.1016\/j.amjmed.2009.01.033_bib13","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.325.7375.1271","article-title":"Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study","volume":"325","author":"Cappuccio","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2009.01.033_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000079951","article-title":"How do American stroke risk functions perform in a Western European population?","volume":"23","author":"Vok\u00f3","year":"2004","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.amjmed.2009.01.033_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1006478317173","article-title":"Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial","volume":"65","author":"Cauley","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.amjmed.2009.01.033_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0002-9149(01)01685-X","article-title":"Design and methods of the Raloxifene Use For the Heart (RUTH) Study","volume":"88","author":"Mosca","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2009.01.033_bib17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0895-4356(03)00124-0","article-title":"Breast cancer risk prediction with a log-incidence model: evaluation of accuracy","volume":"56","author":"Rockhill","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjmed.2009.01.033_bib18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ahj.2007.02.027","article-title":"Prediction of first coronary events with the Framingham score: a systematic review","volume":"153","author":"Eichler","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjmed.2009.01.033_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.amjmed.2007.06.033","article-title":"Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients","volume":"121","author":"O'Regan","year":"2008","journal-title":"Am J Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934309003337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934309003337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:50:35Z","timestamp":1757580635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934309003337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0002934309003337"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.01.033","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Raloxifene and Risk for Stroke Based on the Framingham Stroke Risk Score","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2009.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}